Acute Leukemia Journals

• Associations of Diet Quality With Frailty in Older Adults How does diet quality and protein intake impact frailty in older adults?
  Journal of the American Geriatrics Society, October 2019
• AL Amyloidosis: Advances in Diagnostics and Treatment Recent advances have led to promising new diagnostic strategies and treatment options for AL amyloidosis.
  Nephrology Dialysis Transplantation, October 2019
• Incorporating Precision BH3 Warheads Against AML Venetoclax-based combination therapy offers new hope for the elderly with AML who may be unfit for intensive chemotherapy.
  Journal of Clinical Oncology, September 2019
• Should Preemptive HSCT Be Offered to Those at Risk for AML? For patients with blood disorders capable of developing into AML, do medical and psychological benefits of preemptive HSCT outweigh the risks?
  Journal of Clinical Oncology, September 2019
• Acute Kidney Injury in Patients Receiving Cancer Treatment Which conditions and drugs increase the risk of acute kidney disease in patients with cancer? How long after anticancer therapy do patients remain at risk?
  Journal of the National Cancer Institute, September 2019
• Genetic Testing in the Diagnosis, Biology of Acute Leukemia This workshop examined how molecular genetic findings can aid in the diagnosis of and elucidate the pathogenesis of acute leukemias.
  American Journal of Clinical Pathology, August 2019
• Perioperative Care and Next Generation Cancer Treatments Chimeric antigen receptor t-cell therapy is a novel therapeutic modality which can cause extreme cardiovascular and respiratory compromise. What do anesthesiologists and intensivists need to know?
  Anesthesia & Analgesia, August 2019
• Molecular Genetics in the Diagnosis of Lymphoid Neoplasms This workshop summary highlights the role of molecular genetic testing in the diagnosis of lymphoid neoplasms, as well as its importance in the delivery of prognostic and therapeutic decision-making.
  American Journal of Clinical Pathology, August 2019
• Treatment of Cancer-Associated VTE in the Age of DOACs Are DOACs as safe and effective as LMWH for management of cancer-associated VTE?
  Annals of Oncology, August 2019
• Time-to-Treatment Discontinuation of Therapy in NSCLC Trials Is therapy start date to date of discontinuation or death a potential efficacy endpoint for real-world evidence trials?
  Annals of Oncology, July 2019
• Metronidazole Reduces Endometriosis Progression in Mice Is there a relationship between the gut microbiome and endometriosis? This animal study investigated whether altering gut microbiota with an antibiotic might impact endometriosis progression.
  Human Reproduction, July 2019
• Sepsis Attributed to Bacterial Contamination of Platelets This case series demonstrates the potentially serious consequences of septic transfusion reactions, highlighting the need to monitor recipients for sepsis after platelet transfusions.
  Morbidity & Mortality Weekly Report, July 2019
• Thromboembolic Risk in Systemic Lupus Erythematosus Learn more about the risk factors for thrombosis in patients with SLE and the treatment options for these complications.
  Rheumatology, June 2019
• Pediatric Updates From the Food and Drug Administration Get up-to-date on the latest updates from the FDA regarding potential treatment options for pediatric patients.
  Pediatric Pharmacotherapy, June 2019
• Nivolumab for Relapsed/Refractory DLBCL Does the PD-1 blocking antibody nivolumab offer a survival advantage for patients with relapsed or refractory DLBCL?
  Journal of Clinical Oncology, June 2019
• Allogeneic HCT Provides No Benefit for Hypodiploid ALL Is HCT still indicated for pediatric patients with hypodiploid ALL? New reports call this practice into question.
  Journal of Clinical Oncology, May 2019
• Application of SMART Trial Design in Older Patients With CLL Can a clinical trial in which treatment decisions are guided by intermediate patient outcomes be used in cancers?
  Annals of Oncology, May 2019
• Premature Aging in Young Cancer Survivors Cancer survivors are more likely to experience cardiovascular disease and other chronic health conditions as a result of premature aging. What can be done?
  Journal of the National Cancer Institute, May 2019
• Making Adjuvant Therapy Decisions With Uncertain Data How should adjuvant therapy be used when randomized controlled trial data are lacking? This and other questions about adjuvant therapy have yet to be fully answered.
  Annals of Oncology, April 2019
• Barriers to Cancer Clinical Trial Participation Despite all the potential benefits associated with cancer research, why aren't more patients participating in clinical trials?
  Journal of the National Cancer Institute, April 2019